<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03472456</url>
  </required_header>
  <id_info>
    <org_study_id>6953</org_study_id>
    <nct_id>NCT03472456</nct_id>
  </id_info>
  <brief_title>Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?</brief_title>
  <official_title>Articaine or Eugenol: a Study on the Choice of Endodontic Medication in the Emergency Management of Irreversible Pulpitis of a Mature Permanent Tooth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine which of the two commonly used endodontic&#xD;
      medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in&#xD;
      irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the&#xD;
      pain felt by patients will be carried out a few days apart. The supposed results are that the&#xD;
      medications are equivalent in terms of effectiveness on the pain, but could then present&#xD;
      different economic arguments&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive&#xD;
      endodontic medications (Eugenol or Articaine) in order to determine which one is the more&#xD;
      efficient to control the pain.&#xD;
&#xD;
      These patients would have received the same medication without this study. That's why this is&#xD;
      an obsevationnal study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 22, 2018</start_date>
  <completion_date type="Actual">October 24, 2019</completion_date>
  <primary_completion_date type="Actual">March 22, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pain evolution (decrease or increase the intensity of the pain)</measure>
    <time_frame>7 days</time_frame>
    <description>Evolution of pain (using a score of 0 to 10)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Pulpitides</condition>
  <condition>Endodontic Inflammation</condition>
  <condition>Toothaches</condition>
  <condition>Operative Dentistry</condition>
  <arm_group>
    <arm_group_label>Articaïne</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Eugénol</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne</intervention_name>
    <description>Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne</description>
    <arm_group_label>Articaïne</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol</intervention_name>
    <description>Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol</description>
    <arm_group_label>Eugénol</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the University Hospital (Dental Service) of Strasbourg (HUS)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient, major, affiliated to a social health insurance scheme&#xD;
&#xD;
          -  Patient having agreed to participate in the study&#xD;
&#xD;
          -  Urgent consultant patient for irreversible pulpitis&#xD;
&#xD;
          -  Patient understanding French&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of the patient to participate in the study&#xD;
&#xD;
          -  Impossibility of performing the surgical procedure&#xD;
&#xD;
          -  Impossibility to give the subject information enlightened (difficulty of understanding&#xD;
             ...)&#xD;
&#xD;
          -  Subject under the protection of justice, or under guardianship&#xD;
&#xD;
          -  General contraindication to endodontic treatment in 2 sessions (high risk of&#xD;
             infectious endocarditis, for example)&#xD;
&#xD;
          -  Chronic intake of analgesic drugs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damien OFFNER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2018</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
    <mesh_term>Toothache</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eugenol</mesh_term>
    <mesh_term>Carticaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

